Maternal high-fat diet programming of the neuroendocrine system and behavior
- PMID: 25913366
- PMCID: PMC4619177
- DOI: 10.1016/j.yhbeh.2015.04.008
Maternal high-fat diet programming of the neuroendocrine system and behavior
Abstract
This article is part of a Special Issue "SBN 2014". Maternal obesity, metabolic state, and diet during gestation have profound effects on offspring development. The prevalence of neurodevelopmental and mental health disorders has risen rapidly in the last several decades in parallel with the rise in obesity rates. Evidence from epidemiological studies indicates that maternal obesity and metabolic complications increase the risk of offspring developing behavioral disorders such as attention deficit hyperactivity disorder (ADHD), autism spectrum disorders (ASD), and schizophrenia. Animal models show that a maternal diet high in fat similarly disrupts behavioral programming of offspring, with animals showing social impairments, increased anxiety and depressive behaviors, reduced cognitive development, and hyperactivity. Maternal obesity, metabolic conditions, and high fat diet consumption increase maternal leptin, insulin, glucose, triglycerides, and inflammatory cytokines. This leads to increased risk of placental dysfunction, and altered fetal neuroendocrine development. Changes in brain development that likely contribute to the increased risk of behavioral and mental health disorders include increased inflammation in the brain, as well as alterations in the serotonergic system, dopaminergic system and hypothalamic-pituitary-adrenal (HPA) axis.
Keywords: ADHD; Anxiety; Autism; High-fat diet; Maternal obesity; Pregnancy; Programming; Schizophrenia.
Copyright © 2015 Elsevier Inc. All rights reserved.
References
-
- Abel KM, Dalman C, Svensson AC, Susser E, Dal H, Idring S, Webb RT, Rai D, Magnusson C. Deviance in fetal growth and risk of autism spectrum disorder. The American journal of psychiatry. 2013;170:391–398. - PubMed
-
- Agius M, Verdolini N, Aquilina FF, Butler S. Co-Morbidity Part 2 - Neurobiology and Suicide Risk; Modelling the consequences of Bipolar and Anxiety Co-Morbidity. Psychiatria Danubina. 2014;26(Suppl 1):336–339. - PubMed
-
- Aguilar-Valles A, Jung S, Poole S, Flores C, Luheshi GN. Leptin and interleukin-6 alter the function of mesolimbic dopamine neurons in a rodent model of prenatal inflammation. Psychoneuroendocrinology. 2012;37:956–969. - PubMed
-
- Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. The Journal of endocrinology. 1999;160:1–12. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
